Kim Jun Chul, Dymecki Susan M
Department of Genetics, Harvard Medical School, Boston, MA, USA.
Methods Mol Biol. 2009;493:65-85. doi: 10.1007/978-1-59745-523-7_5.
Greatly impacting the field of neural development are new technologies for generating fate maps in mice and thus for illuminating relationships between embryonic and adult brain structures. Until now, efforts in mammalian models such as the mouse have presented challenges because their in utero development limits the access needed for traditional methods involving tracer injection or cell transplantation. But access is no longer an obstacle. It is now possible to deliver cell lineage tracers via noninvasive genetic, rather than physical, means. The hinge-pin of these new "genetic fate mapping" technologies is a class of molecule called a site-specific recombinase. The most commonly used being Cre and Flp. Through the capacity to produce precise DNA excisions, Cre or Flp can act as an on-switch, capable of transforming a silenced reporter transgene, for example, into a constitutively expressed one. A reporter transgene is, in effect, transformed by the excision event into an indelible cell-lineage tracer, marking ancestor and descendant cells. The actual cell population to be fate mapped is determined by recombinase parameters. Being genetically encoded, Cre or Flp is "delivered" to specific cells in the embryo using transgenics--promoter and enhancer elements from a gene whose expression is restricted to the desired cell type is used to drive recombinase expression. Thus, recombinase delivery is not only noninvasive but also restricted to specific embryonic cells based on their gene expression phenotype, lending molecular precision to the selection of cells for fate mapping. Resolution in cell type selection has recently been improved further by making lineage tracer activation dependent on two DNA excision events rather than just one. Here, in what is referred to as "intersectional genetic fate mapping," lineage tracer is expressed only in those cells having undergone a Flp-dependent excision as well as a Cre-dependent excision, thus marking the embryonic cells lying at the intersection of two gene (Flp and Cre driver) expression domains. The field of hindbrain development, in particular, has seen great advances through application of these new approaches. For example, genetic fate maps of the cochlear nucleus have yielded surprising information about where in the embryonic hindbrain its constituent neurons arise and journey and what genes are expressed along the way. In this chapter, we detail materials and methods relevant to genetic fate mapping in general and intersectional genetic fate mapping in particular.
用于在小鼠中生成命运图谱从而阐明胚胎脑结构与成体脑结构之间关系的新技术,对神经发育领域产生了重大影响。到目前为止,在诸如小鼠等哺乳动物模型中的研究工作面临诸多挑战,因为它们在子宫内的发育限制了传统方法(如示踪剂注射或细胞移植)所需的操作途径。但现在,操作途径已不再是障碍。如今可以通过非侵入性的基因手段而非物理手段来递送细胞谱系示踪剂。这些新的“基因命运图谱”技术的关键是一类称为位点特异性重组酶的分子。最常用的是Cre和Flp。通过产生精确DNA切除的能力,Cre或Flp可以充当一个开关,能够将一个沉默的报告基因转基因,例如,转化为一个组成型表达的转基因。实际上,一个报告基因转基因通过切除事件被转化为一个不可磨灭的细胞谱系示踪剂,标记祖先细胞和后代细胞。实际要进行命运图谱绘制的细胞群体由重组酶参数决定。由于Cre或Flp是基因编码的,利用转基因技术将其“递送至”胚胎中的特定细胞——来自一个基因的启动子和增强子元件,其表达仅限于所需的细胞类型,用于驱动重组酶表达。因此,重组酶的递送不仅是非侵入性的,而且基于特定胚胎细胞的基因表达表型被限制在这些细胞中,为命运图谱绘制的细胞选择赋予了分子层面的精确性。最近,通过使谱系示踪剂的激活依赖于两个DNA切除事件而非仅仅一个,细胞类型选择的分辨率得到了进一步提高。在这里,在所谓的“交叉基因命运图谱”中,谱系示踪剂仅在那些既经历了Flp依赖的切除又经历了Cre依赖的切除的细胞中表达,从而标记位于两个基因(Flp和Cre驱动基因)表达域交集处的胚胎细胞。特别是在后脑发育领域,通过应用这些新方法取得了巨大进展。例如,耳蜗核的基因命运图谱已经产生了关于其组成神经元在胚胎后脑何处产生、迁移以及沿途表达哪些基因的惊人信息。在本章中,我们详细介绍了与一般基因命运图谱绘制特别是交叉基因命运图谱绘制相关的材料和方法。